We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Sequenom Announces Launch of RNA-Based Noninvasive Aneuploidy (RNA) Study

Independent Study Will Document Performance of SEQureDx T21 Technology for Down Syndrome in 10,000 Pregnant Women
News

IonSense Present DART-ET Source for Mass Spectrometry at the Annual Symposium on Chemical and Pharmaceutical Structure Analysis

New technology enables high throughput direct analysis of solid and liquid samples for drug development, food safety, forensics, and medicinal chemistry.
News

Novel Mass Spectrometry-based Assay Reveals Degradation and Low Levels of Bioactive B-type Natriuretic Peptide (BNP) in Patients with Heart Failure

A team of researchers from Intrinsic Bioprobes Inc. report on a novel quantitative mass spectrometry immunoassay for the detection of bioactive B-type natriuretic peptide (BNP).
News

Agilent Technologies, BioTrove to Streamline Drug Discovery Using High-Throughput Mass Spectrometry

Agilent Technologies and BioTrove have signed a non-exclusive value-added reseller agreement to enable BioTrove to provide an end-to-end solution for mass spectrometry-based drug discovery.
News

Nanocort® Demonstrates Safety and Good Response in Phase I/II Trial

Galapagos NV announces that Nanocort has demonstrated safety as well as a faster and more pronounced decrease in rheumatoid arthritis disease symptoms compared to reference medication.
News

State Of The World's Health, WHO Releases The Global Burden Of Disease Study

The World Health Organization (WHO) published a new assessment of the Global Burden of Disease, a study that provides a comprehensive picture of the global and regional state of health.
News

Geron Scientists and Collaborators Demonstrate Activity of Pancreatic Islet-like Cells Derived from Human Embryonic Stem Cells in Diabetes

Survival of Diabetic Mice Improved After Transplantation of hESC-derived ILCs.
News

Incyte’s JAK Inhibitor Demonstrates Rapid and Marked Clinical Improvement in Rheumatoid Arthritis Patients

Incyte Corporation announced the presentation of clinical results from a 28-day Phase IIa trial of INCB18424, its orally available janus kinase (JAK) inhibitor, in patients with rheumatoid arthritis (RA). Results from the 50-patient placebo-controlled trial demonstrated that three of the four doses of INCB18424 evaluated (15 mg BID, 25 mg BID and 50 mg QD) produced impressive clinical benefits and all of the doses were well tolerated. American College of Rheumatology (ACR) 20, ACR50, ACR70 a
News

The Medicines Act Hits 40

The 25th October 2008 will mark the 40th birthday of the Medicines Act. For the past 40 years, the Act has served as the corner-stone of domestic medicines regulation, safe guarding public health.
News

Metabolon and the University of Michigan Announce Agreement

Metabolon the leader in metabolomics-driven biomarker discovery and analysis, and the University of Michigan announced an agreement on the commercial development of prostate cancer diagnostics.
Advertisement